North Nuken – 28grams AAA
Out of stock
$70
Out of stock
Indica Dominant Hybrid – 80% Indica / 20% Sativa
THC: 13% – 21%
North Nuken is an Indica dominant hybrid (80% indica/20% sativa) strain created as cross between Nuken x Northern Lights. This potent bud boasts a moderate THC level between 13-21% and has a deliciously enticing aroma and flavor. This strain is a rare strain and pick it up while you can.
You must be logged in to post a review.
RELATED PRODUCTS
-
*NEW* Black Mamba- 14 Grams (AAAA+)
$80Indica Dominant Hybrid – 70% Indica / 30% Sativa THC: 26-29% An indica dominant strain, Black Mambo was created by crossing Blue Bubblejuice and Domina, which makes it, comprise of genetics from well-known and widely liked strains such as Blueberry and Northern Light. One of the most popular African snakes is the black mamba that is infamous for the potency its venom contains and for the…
-
*NEW* Yoda Og Kush- 28 Grams (AAAA)
$130Indica Dominant Hybrid – 80% Indica / 20% Sativa THC LEVEL= 26%-28% Yoda OG, also known as “Yoda,” “Yoda Kush” or “Yoda OG Kush,” is an indica dominant hybrid strain (80% indica/20% sativa) created as a descendant of the infamous OG Kush strain. Named for the iconic Star…
-
*NEW* Kool-Aid Kush- 14 Grams (AAAA+)
$80Indica Dominant Hybrid – 70% Indica / 30% Sativa THC: 26-29% Kool Aid Kush is an extremely rare indica dominant hybrid strain of unknown heritage due to a general lack of information about it and how incredibly rare it is. Even though not much is known about its heritage, Kool Aid Kush definitely gets its name from its Kool-Aid like…
-
*MIX n MATCH 2 For $100* 🍓 Strawberry Cough – 28grams (AAA)
$60STRAWBERRY COUGH Dominant Hybrid – 60% Sativa / 40% Indica THC 21-23% Strawberry is a strain that holds true to its name. A sweet strawberry smell and subtle after taste is accompanied by a thick smoke that leaves even veteran tokers coughing. This strain is sativa dominant with an 60%/40% sativa/indica ratio. Strawberry Cough is said to be a cross between Erdbeer…
Reviews
There are no reviews yet.